Literature DB >> 1854162

Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.

N Lachance1, C Gaudreau, F Lamothe, L A Larivière.   

Abstract

We studied the role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. beta-Lactamase-positive strains were more resistant than beta-lactamase-negative strains to amoxicillin, ampicillin, and ticarcillin (P less than 0.05). With penicillin G, piperacillin, imipenem, and six cephalosporins, the susceptibility levels were similar for both beta-lactamase-positive and -negative strains. By using spectrophotometric and microbiological assays, the beta-lactamase from three strains hydrolyzed ampicillin, amoxicillin, penicillin G, cloxacillin, and, partially, cephalothin. Ticarcillin and piperacillin were partially hydrolyzed in the microbiological assay. There was no activity against five other cephalosporins or imipenem. Isoelectric focusing of the enzyme showed a pI of 8.8. Tazobactam was the best inhibitor of the enzyme, followed by clavulanic acid, sulbactam, and cefoxitin, while EDTA and p-chloromercuribenzoate had no activity. All beta-lactamase-positive strains became susceptible to amoxicillin and ampicillin with 1 micrograms of clavulanic acid per ml. With the same inhibitor, there was a reduced but significant effect for ticarcillin but no effect for penicillin G or piperacillin. Sulbactam had no effect and tazobactam was effective only at 2 micrograms/ml on amoxicillin and ampicillin. The beta-lactamase of C. jejuni seems to be a penicillinase with a role in resistance for only amoxicillin, ampicillin, and ticarcillin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854162      PMCID: PMC245112          DOI: 10.1128/AAC.35.5.813

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases.

Authors:  L Gutmann; M D Kitzis; S Yamabe; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.

Authors:  N A Kuck; N V Jacobus; P J Petersen; W J Weiss; R T Testa
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

4.  Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.

Authors:  C L Gaudreau; L A Lariviere; J C Lauzer; F F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.

Authors:  L Gutmann; B Ferré; F W Goldstein; N Rizk; E Pinto-Schuster; J F Acar; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

6.  Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances.

Authors:  H Nikaido
Journal:  Biochim Biophys Acta       Date:  1976-04-16

7.  Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.

Authors:  S C Aronoff; M R Jacobs; S Johenning; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

8.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

9.  Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.

Authors:  L A Lariviere; C L Gaudreau; F F Turgeon
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

10.  In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

Authors:  P Van der Auwera; B Scorneaux
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

View more
  23 in total

1.  Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers.

Authors:  Evelyne Guévremont; Eric Nadeau; Marc Sirois; Sylvain Quessy
Journal:  Can J Vet Res       Date:  2006-04       Impact factor: 1.310

2.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998.

Authors:  Y Sáenz; M Zarazaga; M Lantero; M J Gastanares; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

5.  Bacteremia caused by Arcobacter cryaerophilus 1B.

Authors:  P R Hsueh; L J Teng; P C Yang; S K Wang; S C Chang; S W Ho; W C Hsieh; K T Luh
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

Review 6.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different Campylobacter species.

Authors:  Baoqing Guo; Jun Lin; Donald L Reynolds; Qijing Zhang
Journal:  Foodborne Pathog Dis       Date:  2010-01       Impact factor: 3.171

8.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

Authors:  P Tajada; J L Gomez-Graces; J I Alós; D Balas; R Cogollos
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

9.  Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

10.  Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada.

Authors:  C Gaudreau; H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.